FDA revokes Ranbaxy’s right to generic versions of Nexium, Valcyte
November 06, 2014 at 11:04 AM EST
The U.S. Food and Drug Administration revoked Ranbaxy Laboratories’ right to make generic versions of AstraZeneca’s Nexium and Roche’s Valcyte because Ranbaxy’s factories failed to meet manufacturing standards.
